J&J makes yet another recall

Johnson & Johnson (JNJ) is recalling 5,000 vials of its Risperdal Consta schizophrenia treatment after tests found that one lot of the injected drug was contaminated with alternaria alternata, a common mold.

There have so far been no reports of patient complications.

The recall is the latest in a series for J&J, which last week recalled 200,000 bottles of its Motrin Infants Drops formula due to a risk that they contained tiny plastic particles.

From other sites
Comments (3)
  • Dividend Garden
    , contributor
    Comments (489) | Send Message
    You've got to be kidding.
    12 Sep 2013, 09:38 AM Reply Like
  • jumpnjoey77
    , contributor
    Comments (1225) | Send Message
    There is a lot more that is not listed.
    12 Sep 2013, 09:50 AM Reply Like
  • CassandraSees
    , contributor
    Comments (709) | Send Message
    Who is in charge of quality control of the products?
    13 Sep 2013, 02:44 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs